For research access and to learn how you can work with Alembic Global Advisors please email Stephen Matthews, stephen.matthews@alembicglobal.com.
Key Points Q3’24 EBITDA and EPS beat on margin and pricing gains. Q4’24 guidance midpoint below consensus Higher y-o-y EBITDA in Americas and Europe offset somewhat by lower Asia and Middle East...
Key Points We’re reiterating our Overweight rating on shares of HWM after yesterday’s outstanding 2Q earnings release. Our target price rises USD18 to USD110 as we increase our forecast and raise...
Key Points Q2 EPS beat but EBITDA miss; global methanol demand grew q-o-q Lower-than-forecasted volumes in all geographies except Egypt and Medicine Hat. G3 start up ahead of schedule We rate Methanex shares...
Key Points Q2’24 EBITDA and EPS miss; Q3’24 and FY2024 guidance range mid-point below consensus Sequentially higher EBITDA margins in PM segment but lower in S&S segment. Strong y-o-y PM segment volume...
Key Points We’re raising our rating on shares of RTX to Overweight post last week’s 2Q earnings report. We’ve also raised our financial forecast for RTX and our target price rises...